Jessica King Holden
Jessica King Holden
Stop FollowingJessica King Holden
View as an RSS Feed
View Jessica King Holden's Articles BY TICKER:
- Vonage Builds Valuable Intellectual Property
- Which Mid-June Summer Biotech Romance Will Last?
- A Long Shot In The Lupus Market Gains Attention
- Catalyst And Questions For 2 Biotech Movers
- Playing OncoGenex's ASCO Data
- 3 Biotech Stocks With Key FDA Summer Dates
- Vertex's Data Bungle Offers Entry Point
- ASCO Stocks To Consider This Week
- 3 Biotech Stocks On The Move
-
Isis: A Pick To Win The Biotech Derby
- 3 Biotechs To Watch This Week
- 7 Summer Sports Stocks To Consider
- Stocks For A Summer Road Trip
- Friday's U.S. Top Gainers Have A Biotech Flavor
- Cobra Gets It Right In The First Quarter
- Rare Disease Stocks With Takeover Potential
- 2 Biotechs To Watch Near-Term
- 5 Year Projection: Here Comes The Sun?
- EDAP: Now A Compelling Prostate Cancer Play
- Wal-Mart Gets Into Diabetic Neuropathy Testing
- Lightening The Backpack Of Education: E-Readers And E-Textbooks
- Patent Cliff Offers Entry Dips
- Diabetes Market: Eli Lilly's Classic Pharma Vs. Sanofi Aventis' Modern Synergy
- Cashing In On Diabetes: Novel Approaches
- Cashing In On Diabetes: The Race To The Artificial Pancreas
- 4 Rare Disease Stocks
- Biotech Stocks To Consider Going Into Earnings
- Isis: If Trend Holds True, Watch For A Leap After Earnings
- Jazz Pharmaceuticals Can Hit An Interesting Note In 2012
- Cobra Navigating Down For Now, But Not Out
- Cobra Poised To Move On Earnings Release
- Why Herbalife Will Not Be Killed By Prescription Weight Loss Drugs
